Date | Time | Source | Headline | Symbol | Company |
07/17/2024 | 5:00PM | iHub Newswire | FeaturedNightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com | | |
11/03/2008 | 4:31PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/23/2008 | 6:54PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at BIOCOM Investor Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/21/2008 | 4:21PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/21/2008 | 4:06PM | PR Newswire (US) | Amylin Pharmaceuticals Reports Third Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/21/2008 | 4:05PM | PR Newswire (US) | Lilly and Amylin Enter Into Supply Agreement for Exenatide Once Weekly | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/15/2008 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Third Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/10/2008 | 11:46AM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/08/2008 | 10:20AM | PR Newswire (US) | Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: LPX, SHPGY, WNR, WIN, AMLN, STEC | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/06/2008 | 7:20PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/06/2008 | 7:20PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/06/2008 | 7:19PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/06/2008 | 7:19PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/06/2008 | 7:19PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/06/2008 | 7:19PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/06/2008 | 7:18PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/06/2008 | 7:18PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/01/2008 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Soci | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
09/30/2008 | 2:11PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
09/12/2008 | 4:28PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
09/09/2008 | 7:30AM | PR Newswire (US) | First Reported Head-to-Head Study Showed BYETTA(R) (exenatide) Injection Provided Greater Reduction in Post-Meal Glucose Levels | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
08/29/2008 | 4:32PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
08/29/2008 | 4:30PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
08/29/2008 | 4:29PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
08/29/2008 | 10:50AM | PR Newswire (US) | BeaconEquity.com Issues Technical Trade Alerts on BioPharmaceutical Stocks: CEGE, AMLN, DNA, GENZ, AMGN, GILD | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
08/28/2008 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Thomas Weisel Healthcare, BioCentury NewsMakers, and Morgan Stanley Global Healthcare Confe | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
08/28/2008 | 11:11AM | Marketwired | BellwetherReport.com Analyst Opinions on SEED, AMLN, ENER and CPST | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
08/27/2008 | 10:18AM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
08/26/2008 | 5:46PM | PR Newswire (US) | Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
08/25/2008 | 5:00PM | PR Newswire (US) | Amylin and Lilly Set Date and Time for Conference Call | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |